447 related articles for article (PubMed ID: 38778725)
1. Research advancements and perspectives of inflammatory bowel disease: A comprehensive review.
Bai J; Wang Y; Li F; Wu Y; Chen J; Li M; Wang X; Lv B
Sci Prog; 2024; 107(2):368504241253709. PubMed ID: 38778725
[TBL] [Abstract][Full Text] [Related]
2. Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments.
Zhou Y; Wang D; Yan W
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839389
[TBL] [Abstract][Full Text] [Related]
3. Microbiome characterization and re-design by biologic agents for inflammatory bowel disease insights.
Chen W; Chen H; Fu S; Lin X; Zheng Z; Zhang J
Bioprocess Biosyst Eng; 2021 May; 44(5):929-939. PubMed ID: 32458051
[TBL] [Abstract][Full Text] [Related]
4.
Musumeci L; Maugeri A; Cirmi S; Lombardo GE; Russo C; Gangemi S; Calapai G; Navarra M
Nat Prod Res; 2020 Jan; 34(1):122-136. PubMed ID: 30990326
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets.
Yadav V; Varum F; Bravo R; Furrer E; Bojic D; Basit AW
Transl Res; 2016 Oct; 176():38-68. PubMed ID: 27220087
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic Understanding of Herbal Therapy in Inflammatory Bowel Disease.
Zhao L; Zhang S; He P
Curr Pharm Des; 2017; 23(34):5173-5179. PubMed ID: 29032748
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota and metabolites as predictors of biologics response in inflammatory bowel disease: A comprehensive systematic review.
Wang C; Gu Y; Chu Q; Wang X; Ding Y; Qin X; Liu T; Wang S; Liu X; Wang B; Cao H
Microbiol Res; 2024 May; 282():127660. PubMed ID: 38442454
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
9. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives.
Yang C; Merlin D
Int J Nanomedicine; 2019; 14():8875-8889. PubMed ID: 32009785
[TBL] [Abstract][Full Text] [Related]
11. Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?
Lin L; Zhou G; Chen P; Wang Y; Han J; Chen M; He Y; Zhang S
Cell Death Dis; 2020 Jun; 11(6):456. PubMed ID: 32541691
[TBL] [Abstract][Full Text] [Related]
12. Role of long non-coding RNA in inflammatory bowel disease.
Hu Y; Lu Y; Fang Y; Zhang Q; Zheng Z; Zheng X; Ye X; Chen Y; Ding J; Yang J
Front Immunol; 2024; 15():1406538. PubMed ID: 38895124
[TBL] [Abstract][Full Text] [Related]
13. Review of Saccharomyces boulardii as a treatment option in IBD.
Sivananthan K; Petersen AM
Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
[TBL] [Abstract][Full Text] [Related]
14. Effects of proton pump inhibitors on inflammatory bowel disease: An updated review.
Liang Y; Meng Z; Ding XL; Jiang M
World J Gastroenterol; 2024 Jun; 30(21):2751-2762. PubMed ID: 38899331
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of nano formulation of natural products for the treatment of inflammatory bowel disease: drug delivery and pharmacological targets.
Taghipour YD; Bahramsoltani R; Marques AM; Naseri R; Rahimi R; Haratipour P; Iranpanah A; Panah AI; Farzaei MH; Abdollahi M
Daru; 2018 Dec; 26(2):229-239. PubMed ID: 30382546
[TBL] [Abstract][Full Text] [Related]
16. Paediatric Inflammatory Bowel Disease and its Relationship with the Microbiome.
Fitzgerald RS; Sanderson IR; Claesson MJ
Microb Ecol; 2021 Nov; 82(4):833-844. PubMed ID: 33666710
[TBL] [Abstract][Full Text] [Related]
17. Potential of Plant-sourced Phenols for Inflammatory Bowel Disease.
Xiao HT; Wen B; Shen XC; Bian ZX
Curr Med Chem; 2018; 25(38):5191-5217. PubMed ID: 28990509
[TBL] [Abstract][Full Text] [Related]
18. Natural Products: Experimental Efficient Agents for Inflammatory Bowel Disease Therapy.
Cao F; Liu J; Sha BX; Pan HF
Curr Pharm Des; 2019; 25(46):4893-4913. PubMed ID: 31840596
[TBL] [Abstract][Full Text] [Related]
19. Coumarin Derivatives in Inflammatory Bowel Disease.
Di Stasi LC
Molecules; 2021 Jan; 26(2):. PubMed ID: 33467396
[TBL] [Abstract][Full Text] [Related]
20. Discovery of small-molecule candidates against inflammatory bowel disease.
Bai R; Jie X; Yao C; Xie Y
Eur J Med Chem; 2020 Jan; 185():111805. PubMed ID: 31703817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
